speb/financial-data huggingface dataset:
Stock screener scorecard for HURA (quarterly, report date 2026-03-31)
Altman Z-score: 4.566079403900366 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -642.5882414923874%
Capitalized R&D asset: 10929339.9
ROCI (R&D adjusted): -22.322381739428675%
Rule of 40 score: 0
Market cap: 134370128 (Micro Cap ($50M-$300M))
Debt to equity: 0.0197
Free cash flow (dilution adjusted): -7258039
Operating income: -7529899
Net income: -7536598
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for HVMC (quarterly, report date 2026-03-31)
Altman Z-score: 18.87993251648367 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.737041736177978%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.12216793792053904%
Rule of 40 score: 0
Market cap: 299687872 (Micro Cap ($50M-$300M))
P/E ratio: 49.31156915944309
Debt to equity: 0
Free cash flow (dilution adjusted): -192839
Operating income: -288569
Net income: 1673135
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for MAHLIFE.NS (annual, report date 2026-03-31)
Altman Z-score: 1.4465769094011445 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.385036065808507%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.9770509379324435%
Free cash flow margin: -48.43243025800245%
Revenue growth: 186.93399805627163%
Rule of 40 score: 138.50156779826918
Market cap: 71608483840 (Large Cap ($10B-$200B))
P/E ratio: 0.2104950272824607
Debt to equity: 0.1826
Free cash flow (dilution adjusted): -60479684.188215345
Operating income: -15387399.321746502
Net income: 31598675.286138196
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for MAHLIFE.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 43.03118900750421%
Rule of 40 score: 43.03118900750421
Market cap: 79928852480 (Large Cap ($10B-$200B))
P/E ratio: 0.24391833640975055
Debt to equity: 0.1826
Operating income: 9435594.471990716
Net income: 9025213.63012976
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MOBX (quarterly, report date 2026-03-31)
Altman Z-score: -7.243121180302708 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 923130
ROCI (R&D adjusted): -52.369431705716806%
Rosenberg metric: -0.8981900452488688
Free cash flow margin: -691.2371134020619%
Revenue growth: -48.266666666666666%
Rule of 40 score: -739.5037800687286
Market cap: 27509606 (Nano Cap (< $50M))
Debt to equity: 0.7529
Free cash flow (dilution adjusted): -6705000
Operating income: -6091000
Net income: -5853000
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for MPCES.OL (quarterly, report date 2026-03-31)
Altman Z-score: 2.377739933920078 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.1314173049215137%
Free cash flow margin: -98.21138211382113%
Rule of 40 score: -98.21138211382113
Market cap: 307050016 (Small Cap ($300M-$2B))
Debt to equity: 0.5941
Free cash flow (dilution adjusted): -1388505.7471264368
Operating income: -857471.264367816
Net income: -279310.3448275862
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for NCT (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 32887194 (Nano Cap (< $50M))
Debt to equity: 0.5912
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NXTC (quarterly, report date 2026-03-31)
Altman Z-score: -15.71011423628906 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -35.60787543045366%
Capitalized R&D asset: 13414880
ROCI (R&D adjusted): -22.159112359126382%
Rule of 40 score: 0
Market cap: 15315286 (Nano Cap (< $50M))
Debt to equity: 0.1839
Free cash flow (dilution adjusted): -13707000
Operating income: -10105000
Net income: -9796000
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for OGI.TO (quarterly, report date 2026-03-31)
Altman Z-score: -0.349710411294046 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 3224096.150816573
ROCI (R&D adjusted): -2.333411799240033%
Rosenberg metric: -3.4280575539568328
Free cash flow margin: -8.301222535876436%
Revenue growth: -5.550674607963855%
Rule of 40 score: -13.85189714384029
Market cap: 185823040 (Micro Cap ($50M-$300M))
Debt to equity: 0.019299999999999998
Free cash flow (dilution adjusted): -5564028.776978417
Operating income: -7045323.741007195
Net income: -662589.9280575541
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for OMAXE.NS (quarterly, report date 2026-03-31)
Altman Z-score: -0.004422494402292698 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -24.75216309945008%
Revenue growth: 9.855798097448595%
Rule of 40 score: 9.855798097448595
Market cap: 16099135488 (Large Cap ($10B-$200B))
Debt to equity: -1.6427170978186556
Operating income: -22465027.554048326
Net income: -20273420.941076726
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for OMAXE.NS (annual, report date 2026-03-31)
Altman Z-score: -0.0531873167759061 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -85.2792470895951%
Free cash flow margin: 14.554810914313068%
Revenue growth: -27.21014015244035%
Rule of 40 score: -12.655329238127281
Market cap: 16099135488 (Large Cap ($10B-$200B))
Debt to equity: -1.6427170978186556
Free cash flow (dilution adjusted): 19333403.984739296
Operating income: -77399321.74650276
Net income: -73844955.48961425
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for PIC.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 443054080 (Small Cap ($300M-$2B))
P/E ratio: 8.206245461147422
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PIC.AX (annual, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.548509970871611%
Capitalized R&D asset: 0
Free cash flow margin: 140.6388988085576%
Revenue growth: -27.37652500338326%
Rule of 40 score: 113.26237380517433
Market cap: 443054080 (Small Cap ($300M-$2B))
P/E ratio: 8.206245461147422
Debt to equity: 0
Free cash flow (dilution adjusted): 28314379.08496732
Net income: 14196732.026143791
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for RCN.L (quarterly, report date 2025-09-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 178439776 (Micro Cap ($50M-$300M))
P/E ratio: 0.891891891891892
Debt to equity: 0.8517
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for S (quarterly, report date 2026-04-30)
Altman Z-score: 2.9388691627976535 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.701583614657048%
Capitalized R&D asset: 183081390
ROCI (R&D adjusted): -3.928149276392384%
Rosenberg metric: 0.02080279310229066
Free cash flow margin: -15.987305580556429%
Revenue growth: 2.0298503059158484%
Rule of 40 score: -13.95745527464058
Market cap: 6218459136 (Mid Cap ($2B-$10B))
Debt to equity: 0
Free cash flow (dilution adjusted): -44230000
Operating income: -79686000
Net income: -76164000
Long score: 4 | Short score: 13
Recommendation: Short
Stock screener scorecard for S32.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10529368064 (Large Cap ($10B-$200B))
P/E ratio: 0.33783783783783783
Debt to equity: 0.1825
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SFZN.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3097256448 (Mid Cap ($2B-$10B))
P/E ratio: 24.465981012658226
Debt to equity: 0.5101
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SLBEN.LS (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 152720000 (Micro Cap ($50M-$300M))
P/E ratio: 5
Debt to equity: 1.3299
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SPX.V (quarterly, report date 2026-01-31)
Altman Z-score: 6.483322201211529 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.48786106239986%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -14.329197126268555%
Rule of 40 score: 0
Market cap: 5197664 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -428971.11111111107
Operating income: -401058.5185185185
Net income: -237565.9259259259
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for STARHEALTH.NS (annual, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.3571184523825295%
Capitalized R&D asset: 0
Free cash flow margin: 10.071412543475821%
Revenue growth: 0.3584107459114989%
Rule of 40 score: 10.42982328938732
Market cap: 341744746496 (Mega Cap (>= $200B))
P/E ratio: 0.5097114799057808
Debt to equity: 0.0622415980464084
Free cash flow (dilution adjusted): 190263883.00127172
Net income: 59028189.910979226
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for STARHEALTH.NS (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.4744637290398108%
Capitalized R&D asset: 0
Revenue growth: -3.165639760884309%
Rule of 40 score: -3.165639760884309
Market cap: 341744746496 (Mega Cap (>= $200B))
P/E ratio: 0.5097114799057808
Debt to equity: 0.0622415980464084
Net income: 11799491.309877066
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for TARS (quarterly, report date 2026-03-31)
Altman Z-score: 6.626419053771129 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.6123747531631683%
Capitalized R&D asset: 39808170
ROCI (R&D adjusted): -0.5573531585450648%
Rosenberg metric: 0.6607707235930136
Free cash flow margin: -26.186950029002677%
Revenue growth: 6.847851887016378%
Rule of 40 score: -19.339098141986298
Market cap: 2559397376 (Mid Cap ($2B-$10B))
Debt to equity: 0.2541
Free cash flow (dilution adjusted): -42437000
Operating income: -6122000
Net income: -6967000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for TSD.V (quarterly, report date 2025-12-31)
Altman Z-score: -32.19385449310203 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8668265 (Nano Cap (< $50M))
Debt to equity: -1.25635215691926
Free cash flow (dilution adjusted): -38487.59124087591
Operating income: -298009.48905109486
Net income: -423881.7518248175
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TSD.V (annual, report date 2025-12-31)
Altman Z-score: -32.97380482083016 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8668265 (Nano Cap (< $50M))
Debt to equity: -1.25635215691926
Free cash flow (dilution adjusted): -433468.6131386861
Operating income: -767087.5912408759
Net income: -3106260.5839416054
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for UBI.PA (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 800717504 (Small Cap ($300M-$2B))
Debt to equity: 1.2882
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for UBI.PA (annual, report date 2026-03-31)
Altman Z-score: -0.8773277150819252 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 3324597350.5182896
ROCI (R&D adjusted): -12.903663724200282%
Rosenberg metric: -0.2633203472960065
Free cash flow margin: -34.2767070287311%
Revenue growth: -17.32971244731076%
Rule of 40 score: -51.606419476041864
Market cap: 800717504 (Small Cap ($300M-$2B))
Debt to equity: 1.2882
Free cash flow (dilution adjusted): -549885057.4712644
Operating income: -1509310344.8275862
Net income: -1695632183.908046
Long score: 0 | Short score: 8
Recommendation: Short
Stock screener scorecard for VMO (annual, report date 2026-02-28)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.7952496774667996%
Capitalized R&D asset: 0
Free cash flow margin: 275.58787761135767%
Revenue growth: -19.224270469781953%
Rule of 40 score: 256.3636071415757
Market cap: 647430656 (Small Cap ($300M-$2B))
P/E ratio: 34.75
Debt to equity: 0.5558
Free cash flow (dilution adjusted): 54457165
Net income: 19291694
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VMO (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 647430656 (Small Cap ($300M-$2B))
P/E ratio: 34.75
Debt to equity: 0.5558
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for VRNS (quarterly, report date 2026-03-31)
Altman Z-score: 2.293740520119659 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -20.803815319016632%
Capitalized R&D asset: 133759610
ROCI (R&D adjusted): -3.5784005420587275%
Rosenberg metric: -0.08132157226864747
Free cash flow margin: 8.828252255582639%
Revenue growth: -0.1401634663636521%
Rule of 40 score: 8.688088789218986
Market cap: 5372059136 (Mid Cap ($2B-$10B))
Debt to equity: 1.1514
Free cash flow (dilution adjusted): 15284000
Operating income: -44481000
Net income: -36854000
Long score: 3 | Short score: 12
Recommendation: Short
Stock screener scorecard for VSTD (quarterly, report date 2025-06-30)
Altman Z-score: -1.2618812361422154 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -52.601477051741774%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -12.418375022638402%
Free cash flow margin: -30.259749413110544%
Revenue growth: 5.044465940294248%
Rule of 40 score: -25.215283472816296
Market cap: 1432163 (Nano Cap (< $50M))
Debt to equity: 2.639
Free cash flow (dilution adjusted): -1116264
Operating income: -1702573
Net income: -1203971
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 0789.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 622265018.75 (Small Cap ($300M-$2B))
Debt to equity: 0.01897518284257002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1004.HK (quarterly, report date 2024-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 140615270.4 (Micro Cap ($50M-$300M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2778.T (annual, report date 2026-02-28)
Altman Z-score: 2.5995105668703946 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.543287307879122%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.595027347764991%
Free cash flow margin: -3.1170134239983125%
Revenue growth: -9.884134407492553%
Rule of 40 score: -13.001147831490865
Market cap: 1860777345 (Small Cap ($300M-$2B))
P/E ratio: 86.9400245292716
Debt to equity: 1.040003443770321
Free cash flow (dilution adjusted): -2816354.420633902
Operating income: 1221346.0798152187
Net income: 137321.95560118053
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 2999.T (annual, report date 2025-08-31)
Altman Z-score: 2.465058400447849 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.478253749013761%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.91839282498714%
Free cash flow margin: -11.928318528163972%
Revenue growth: -13.12973887717615%
Rule of 40 score: -25.058057405340122
Market cap: 4660118400 (Mid Cap ($2B-$10B))
P/E ratio: 12.019133148494422
Debt to equity: 1.3353602382851206
Free cash flow (dilution adjusted): -14110620.614483276
Operating income: 3840452.346890115
Net income: 2641358.4031609786
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 3823.T (annual, report date 2025-08-31)
Altman Z-score: 5.909883624360056 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.234200454194935%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.582024919074626%
Free cash flow margin: -6.46848285993061%
Revenue growth: 131.24457261743996%
Rule of 40 score: 124.77608975750934
Market cap: 10119386200 (Large Cap ($10B-$200B))
Debt to equity: 0.21257795467221013
Free cash flow (dilution adjusted): -771837.3186184346
Operating income: -497016.1455139996
Net income: -382137.74780298385
Long score: 7 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for 4829.T (annual, report date 2025-05-31)
Altman Z-score: 6.190335209425765 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.311583758442026%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.3609372576115857%
Free cash flow margin: 0.6756703521072067%
Revenue growth: 3.25375867947442%
Rule of 40 score: 3.929429031581627
Market cap: 4389895808 (Mid Cap ($2B-$10B))
P/E ratio: 115.36570503521497
Debt to equity: 0
Free cash flow (dilution adjusted): 208756.43343997773
Operating income: 471658.08874669636
Net income: 264654.3330087634
Long score: 8 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 5271.T (annual, report date 2026-02-28)
Altman Z-score: 1.3195049214675731 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.0195672943268999%
Free cash flow margin: 9.16225702264839%
Revenue growth: -21.874447592172586%
Rule of 40 score: -12.712190569524196
Market cap: 3171641634 (Mid Cap ($2B-$10B))
Debt to equity: 2.1586650512624757
Free cash flow (dilution adjusted): 6872488.130373412
Operating income: 657448.9926857436
Net income: -1418542.2815347104
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 6085.T (annual, report date 2025-03-31)
Altman Z-score: -0.4522021649856549 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -108.96040801072783%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.217718116318847%
Free cash flow margin: -14.268141585032135%
Revenue growth: 53.22352955979813%
Rule of 40 score: 38.955387974766
Market cap: 1866832165.1999998 (Small Cap ($300M-$2B))
Debt to equity: 5.688503196626539
Free cash flow (dilution adjusted): -855874.8830370271
Operating income: -750494.586285256
Net income: -534046.2505012698
Long score: 0 | Short score: 13
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 9237.T (annual, report date 2025-10-31)
Altman Z-score: 7.032417830248545 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.596837878253272%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.094933964622888%
Free cash flow margin: 2.33578770167652%
Revenue growth: 43.23935411254269%
Rule of 40 score: 45.575141814219215
Market cap: 4296668640 (Mid Cap ($2B-$10B))
P/E ratio: 47.91645633991301
Debt to equity: 0.15431470458797697
Free cash flow (dilution adjusted): 284269.0058479532
Operating income: 744951.2670565302
Net income: 582651.0721247563
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ABSI (annual, report date 2025-12-31)
Altman Z-score: 7.971341325251536 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -70.06185148882955%
Capitalized R&D asset: 140065640
ROCI (R&D adjusted): -32.50862326244274%
Free cash flow margin: -4012.6071428571427%
Revenue growth: -38.244375827084255%
Rule of 40 score: -4050.851518684227
Market cap: 591207162.1700001 (Small Cap ($300M-$2B))
Debt to equity: 0.027986423786876678
Free cash flow (dilution adjusted): -112353000
Operating income: -125418000
Net income: -115183000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for AROW (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.672761996643057%
Capitalized R&D asset: 0
Free cash flow margin: 21.167781830478997%
Revenue growth: 18.44699083015035%
Rule of 40 score: 39.61477266062935
Market cap: 510416106.71999997 (Small Cap ($300M-$2B))
P/E ratio: 11.612770612244898
Debt to equity: 0.06760186360141901
Free cash flow (dilution adjusted): 35053000
Net income: 43953000
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for AVCR.V (annual, report date 2025-12-31)
Altman Z-score: -69.4025240725294 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -464.01693187973126%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -325.09061412245484%
Free cash flow margin: -221.95308344134682%
Revenue growth: -88.35563240191692%
Rule of 40 score: -310.3087158432637
Market cap: 6318483.2 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -864943.0656934306
Operating income: -924405.8394160583
Net income: -1356749.6350364962
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CXI.TO (annual, report date 2025-10-31)
Altman Z-score: 4.294585918227172 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.407989479432192%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 23.428514862256833%
Free cash flow margin: 18.1609490722717%
Revenue growth: 5.117096847498262%
Rule of 40 score: 23.27804591976996
Market cap: 102654112.67857143 (Micro Cap ($50M-$300M))
P/E ratio: 9.94826650077242
Debt to equity: 0.06958812787590941
Free cash flow (dilution adjusted): 13157262
Operating income: 21198806
Net income: 10318794
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for DH (annual, report date 2025-12-31)
Altman Z-score: -0.5735477152259572 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 73248590
ROCI (R&D adjusted): -3.638091273746443%
Rosenberg metric: -0.38868503203899446
Free cash flow margin: 3.2763196575039024%
Revenue growth: -4.235097263304811%
Rule of 40 score: -0.958777605800909
Market cap: 302854563.06 (Small Cap ($300M-$2B))
Debt to equity: 0.45559273018955543
Free cash flow (dilution adjusted): 7913000
Operating income: -20583000
Net income: -138932000
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for ENG.MC (annual, report date 2025-12-31)
Altman Z-score: 0.7811755539884978 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 23.179077325499545%
Capitalized R&D asset: 2676916.053921569
ROCI (R&D adjusted): 4.292593293328253%
Rosenberg metric: 133.93609102215672
Free cash flow margin: 9.831310046532646%
Revenue growth: 19.782781684783984%
Rule of 40 score: 29.61409173131663
Market cap: 3302124155.2000003 (Mid Cap ($2B-$10B))
P/E ratio: 9.719762740740522
Debt to equity: 1.2183701074435311
Free cash flow (dilution adjusted): 111082352.94117647
Operating income: 278302352.9411765
Net income: 399685882.3529412
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ESCT.L (annual, report date 2025-06-30)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 17.634825927151603%
Capitalized R&D asset: 0
Free cash flow margin: 234.14221097987092%
Revenue growth: 16.001250895717202%
Rule of 40 score: 250.14346187558812
Market cap: 6940230.9697 (Nano Cap (< $50M))
P/E ratio: 0.07706486969030724
Debt to equity: 0.016021869009178014
Free cash flow (dilution adjusted): 299246575.34246576
Net income: 123365753.42465754
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for FC (annual, report date 2025-08-31)
Altman Z-score: 2.611702644318556 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 340.6140350877193%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.514132212099975%
Free cash flow margin: 2.3529676073794215%
Revenue growth: -7.020781038390436%
Rule of 40 score: -4.667813431011014
Market cap: 220908155.88 (Micro Cap ($50M-$300M))
P/E ratio: 72.0039621512386
Debt to equity: 0.012299920790303537
Free cash flow (dilution adjusted): 6284000
Operating income: 12427000
Net income: 3068000
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for FDBC (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.675946170946582%
Capitalized R&D asset: 0
Free cash flow margin: 25.960118572319267%
Revenue growth: 14.393503340924449%
Rule of 40 score: 40.353621913243714
Market cap: 247939237.8 (Micro Cap ($50M-$300M))
P/E ratio: 8.7927951556848
Debt to equity: 0.07061458594992882
Free cash flow (dilution adjusted): 23733000
Net income: 28198000
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for FORA.TO (annual, report date 2025-12-31)
Altman Z-score: -0.003967432820615624 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.0807551894469745%
Free cash flow margin: 25.205996989865447%
Revenue growth: -12.105779159149375%
Rule of 40 score: 13.100217830716073
Market cap: 59923923.51 (Micro Cap ($50M-$300M))
Debt to equity: 0.6061007188487231
Free cash flow (dilution adjusted): 10698057.664233575
Operating income: -3570098.5401459853
Net income: -5855248.175182481
Long score: 3 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for HURA (annual, report date 2025-12-31)
Altman Z-score: -6.052758817037541 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 32570129.33
ROCI (R&D adjusted): -39.2193825654789%
Rule of 40 score: 0
Market cap: 48398721.28 (Nano Cap (< $50M))
Debt to equity: 0.03344214747638199
Free cash flow (dilution adjusted): -34129963
Operating income: -27289239
Net income: -30051977
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for HVMC (annual, report date 2025-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 236600000 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MOBX (annual, report date 2025-09-30)
Altman Z-score: -7.445109060165821 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 9935450
ROCI (R&D adjusted): -212.65726841601148%
Rosenberg metric: 0.42481398165772627
Free cash flow margin: -360.7546408393866%
Revenue growth: 53.865259236262034%
Rule of 40 score: -306.88938160312455
Market cap: 120885387.22000001 (Micro Cap ($50M-$300M))
Debt to equity: -19.508928571428573
Free cash flow (dilution adjusted): -35758000
Operating income: -36968000
Net income: -46131000
Long score: 1 | Short score: 14
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MPCES.OL (annual, report date 2025-12-31)
Altman Z-score: -0.11501109885749039 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -39.836284169197725%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.5713216584343663%
Free cash flow margin: -241.4275466284075%
Revenue growth: -14.469645524921908%
Rule of 40 score: -255.8971921533294
Market cap: 25147597.11155379 (Nano Cap (< $50M))
Debt to equity: 0.6046057082717318
Free cash flow (dilution adjusted): -15837647.05882353
Operating income: -2807058.823529412
Net income: -10631764.705882354
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for NCT (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 51558.258642765686
Rule of 40 score: 0
Market cap: 6112116367.5 (Mid Cap ($2B-$10B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NXTC (annual, report date 2025-12-31)
Altman Z-score: -13.14033405097193 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -153.56151446641672%
Capitalized R&D asset: 88537190
ROCI (R&D adjusted): -44.84727863105113%
Rule of 40 score: 0
Market cap: 51255642.239999995 (Micro Cap ($50M-$300M))
Debt to equity: 0.14746873479666886
Free cash flow (dilution adjusted): -52599000
Operating income: -57616000
Net income: -55844000
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for OGI.TO (annual, report date 2025-09-30)
Altman Z-score: 0.5676232686381271 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -9.550373848727302%
Capitalized R&D asset: 14934497.1005384
ROCI (R&D adjusted): -3.0550890082666404%
Rosenberg metric: 3.5799871531346357
Free cash flow margin: -7.162643156060584%
Revenue growth: 58.36501270086409%
Rule of 40 score: 51.20236954480351
Market cap: 396985562.03999996 (Small Cap ($300M-$2B))
Debt to equity: 0.025068026236645377
Free cash flow (dilution adjusted): -20760431.654676262
Operating income: -11007194.244604317
Net income: -17812230.21582734
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for S (annual, report date 2026-01-31)
Altman Z-score: 1.7657675000212183 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -100.40235385869758%
Capitalized R&D asset: 574742420
ROCI (R&D adjusted): -11.294890095252475%
Rosenberg metric: 0.4934270155279736
Free cash flow margin: -24.558713963554577%
Revenue growth: 21.889901042167555%
Rule of 40 score: -2.6688129213870226
Market cap: 4707695267.76 (Mid Cap ($2B-$10B))
Debt to equity: 0.010438056006874741
Free cash flow (dilution adjusted): -245901000
Operating income: -309044000
Net income: -450735000
Long score: 2 | Short score: 14
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for SLBEN.LS (annual, report date 2025-06-30)
Altman Z-score: 0.07111372782946024 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -128.67793630613235%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.924291060826413%
Free cash flow margin: -46.96988092863524%
Revenue growth: 42.90751428910296%
Rule of 40 score: -4.062366639532279
Market cap: 120980000.00000001 (Micro Cap ($50M-$300M))
P/E ratio: 3.5123679015213094
Debt to equity: 1.7478012672266316
Free cash flow (dilution adjusted): -127436470.5882353
Operating income: -43921176.47058824
Net income: 40522352.941176474
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for SPX.V (annual, report date 2025-07-31)
Altman Z-score: -37.56585124509155 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -260.4566384889943%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -211.4515180582608%
Rule of 40 score: 0
Market cap: 6497080.300000001 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -941359.4202898551
Operating income: -784318.115942029
Net income: -966088.4057971016
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TARS (annual, report date 2025-12-31)
Altman Z-score: 9.949805912342965 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.157055287746235%
Capitalized R&D asset: 116693580
ROCI (R&D adjusted): -11.535102210612392%
Rosenberg metric: 4.693159255235455
Free cash flow margin: -14.18601559730592%
Revenue growth: 146.70817095100927%
Rule of 40 score: 132.52215535370334
Market cap: 3572510537.7599998 (Mid Cap ($2B-$10B))
Debt to equity: 0.210927536063082
Free cash flow (dilution adjusted): -64030000
Operating income: -70969000
Net income: -66418000
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for VRNS (annual, report date 2025-12-31)
Altman Z-score: 1.7211995638618665 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -29.022841190705922%
Capitalized R&D asset: 430313090
ROCI (R&D adjusted): -7.347494855125289%
Rosenberg metric: 0.17510736157345055
Free cash flow margin: 0.2675083235503551%
Revenue growth: 13.173972229784917%
Rule of 40 score: 13.441480553335273
Market cap: 3765904119.9999995 (Mid Cap ($2B-$10B))
Debt to equity: 0.8715305617917468
Free cash flow (dilution adjusted): 1668000
Operating income: -146514000
Net income: -129324000
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for VSTD (annual, report date 2024-12-31)
Altman Z-score: -0.6169373084349774 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -22.155651964065413%
Free cash flow margin: 0.8855501736604259%
Revenue growth: 39.33201219475801%
Rule of 40 score: 40.217562368418434
Market cap: 11582483.6 (Nano Cap (< $50M))
Debt to equity: 60.28314128089773
Free cash flow (dilution adjusted): 113697
Operating income: -2555029
Net income: -2665869
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 0031.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1511660800 (Small Cap ($300M-$2B))
Debt to equity: 0.20850000000000002
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 0696.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 24667947008 (Large Cap ($10B-$200B))
P/E ratio: 1.3655084722337396
Debt to equity: 0.0837
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 0924.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 124000000 (Micro Cap ($50M-$300M))
Debt to equity: 0.0118
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1199.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 20605726720 (Large Cap ($10B-$200B))
P/E ratio: 1.0985700514138816
Debt to equity: 0.5303
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1354.HK (annual, report date 2025-12-31)
Altman Z-score: 1.7632041344353975 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 21.351146314178806%
Capitalized R&D asset: 352338.755810977
ROCI (R&D adjusted): 28.4553486325701%
Rosenberg metric: 55.3798355162961
Free cash flow margin: 2.223560785270554%
Revenue growth: 14.992479006300993%
Rule of 40 score: 17.216039791571546
Market cap: 126000248 (Micro Cap ($50M-$300M))
P/E ratio: 42.41645244215938
Debt to equity: 0.266
Free cash flow (dilution adjusted): 3332857.1428571427
Operating income: 13442000
Net income: 9455428.57142857
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1354.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 126000248 (Micro Cap ($50M-$300M))
P/E ratio: 42.41645244215938
Debt to equity: 0.266
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1789.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5817825280 (Mid Cap ($2B-$10B))
P/E ratio: 2.0455380095482925
Debt to equity: 0.0297
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1942.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1188909285376 (Mega Cap (>= $200B))
P/E ratio: 0.11760574068167708
Debt to equity: 0.0347
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2189.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 490000000 (Small Cap ($300M-$2B))
P/E ratio: 1.8851756640959725
Debt to equity: 0.5943999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 251A.T (annual, report date 2026-02-28)
Altman Z-score: 3.173812887804288 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 20.19197176676792%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.792644369676789%
Free cash flow margin: 6.655418588380499%
Revenue growth: -7.935018248500393%
Rule of 40 score: -1.279599660119894
Market cap: 210841600 (Micro Cap ($50M-$300M))
P/E ratio: 7.636421586381745
Debt to equity: 1.1845
Free cash flow (dilution adjusted): 496811.24085717945
Operating income: 172526.62645964324
Net income: 177146.15680739123
Long score: 8 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 251A.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 210841600 (Micro Cap ($50M-$300M))
Debt to equity: 1.1845
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 2978.T (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4102871808 (Mid Cap ($2B-$10B))
P/E ratio: 0.49890284756392256
Debt to equity: 2.4306
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3396.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 31549933568 (Large Cap ($10B-$200B))
P/E ratio: 3.0570416174529287
Debt to equity: 1.5969642054441762
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 3396.HK (annual, report date 2025-12-31)
Altman Z-score: 0.7584456911636096 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -46.84295844323699%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.25962928905396%
Free cash flow margin: 1.0381788196575445%
Revenue growth: 22.48039940574314%
Rule of 40 score: 23.518578225400685
Market cap: 31549933568 (Large Cap ($10B-$200B))
P/E ratio: 3.0570416174529287
Debt to equity: 1.5969642054441762
Free cash flow (dilution adjusted): 909436285.7142857
Operating income: 2647191857.142857
Net income: 1399855000
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3437.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4355215872 (Mid Cap ($2B-$10B))
P/E ratio: 0.061876488866491296
Debt to equity: 0.213
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3437.T (annual, report date 2026-03-31)
Altman Z-score: 3.0360828807596976 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.390137459510435%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.35385679605201%
Free cash flow margin: 1.6431389193521657%
Revenue growth: -3.0561924004328955%
Rule of 40 score: -1.4130534810807298
Market cap: 4355215872 (Mid Cap ($2B-$10B))
P/E ratio: 0.061876488866491296
Debt to equity: 0.213
Free cash flow (dilution adjusted): 1122122.1221221222
Operating income: 3650206.4564564563
Net income: 2870689.439439439
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 4445.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3997568512 (Mid Cap ($2B-$10B))
P/E ratio: 0.09653852797246659
Debt to equity: 0.8829
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4446.T (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11395921920 (Large Cap ($10B-$200B))
Debt to equity: 0.5966
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4494.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3077403904 (Mid Cap ($2B-$10B))
P/E ratio: 0.21157440188549384
Debt to equity: 0.1858
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4494.T (annual, report date 2026-02-28)
Altman Z-score: 2.508707749313153 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 26.11502546922035%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.265621875586076%
Free cash flow margin: 18.118449125905183%
Revenue growth: 2.5649366436440104%
Rule of 40 score: 20.683385769549194
Market cap: 3077403904 (Mid Cap ($2B-$10B))
P/E ratio: 0.21157440188549384
Debt to equity: 0.1858
Free cash flow (dilution adjusted): 3304536.1221609134
Operating income: 1939407.1602720388
Net income: 678891.3127165404
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for 4587.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 120731426816 (Large Cap ($10B-$200B))
Debt to equity: 0.3285
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4845.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5683456000 (Mid Cap ($2B-$10B))
P/E ratio: 0.06392761712694323
Debt to equity: 0.8401000000000001
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 5715.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 116105674752 (Large Cap ($10B-$200B))
P/E ratio: 0.06923553374696448
Debt to equity: 0.39159999999999995
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6033.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 9103003648 (Mid Cap ($2B-$10B))
P/E ratio: 0.04124159644836593
Debt to equity: 0.08990000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6080.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 118692995072 (Large Cap ($10B-$200B))
P/E ratio: 0.09961059299929369
Debt to equity: 0.0548
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7849.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12928704512 (Large Cap ($10B-$200B))
P/E ratio: 0.067590764726254
Debt to equity: 0.0128
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7970.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 181398978560 (Large Cap ($10B-$200B))
P/E ratio: 0.09819350945812157
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8056.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18146326 (Nano Cap (< $50M))
P/E ratio: 0.061473119481390406
Debt to equity: -0.024130207555621924
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 8350.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 361024320 (Small Cap ($300M-$2B))
P/E ratio: 0.9254498714652956
Debt to equity: 0.08460000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8350.HK (annual, report date 2025-12-31)
Altman Z-score: 7.717680901926823 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 39.35666780354707%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 28.723702315503726%
Free cash flow margin: 49.596024780588536%
Revenue growth: 71.52932619103291%
Rule of 40 score: 121.12535097162144
Market cap: 361024320 (Small Cap ($300M-$2B))
P/E ratio: 0.9254498714652956
Debt to equity: 0.08460000000000001
Free cash flow (dilution adjusted): 4939203.084832905
Operating income: 5929820.051413882
Net income: 7107712.082262211
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 8419.HK (annual, report date 2025-12-31)
Altman Z-score: 0.6564581508674294 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -9.590005278901995%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7869265624581064%
Free cash flow margin: -0.29182338663356244%
Revenue growth: -14.475272157714878%
Rule of 40 score: -14.76709554434844
Market cap: 28000000 (Nano Cap (< $50M))
Debt to equity: 1.1586
Free cash flow (dilution adjusted): -40488.43187660668
Operating income: 75449.87146529563
Net income: -715809.7686375321
Long score: 0 | Short score: 8
Recommendation: Short
Stock screener scorecard for 8419.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 28000000 (Nano Cap (< $50M))
Debt to equity: 1.1586
Long score: 0 | Short score: 2
Recommendation: Neutral